The Canadian Federal Court's recent decision in Steelhead LNG (ASLNG) Ltd. v. ARC Resources Ltd., 2022 FC 998 ("the Decision") held that mere design and promotional activities...

Making sure a startup has the right branding in place will help distinguish it from its competitors.

The Patented Medicine Prices Review Board (PMPRB) is a Canadian federal agency that regulates the prices of patented medicines in Canada.

Recently, the Federal Court of Appeal released its decision in Pharmascience Inc. v. Bristol-Myers Squibb Canada Co., 2022 2022 FCA 142 142 (the "Decision").

In 2012, a fledgling startup, AdSupply Inc., filed a patent application for a method for delivering leave behind ads which are displayed behind the browser window when a user leaves a website.

As explained in our previous article, in order to comply with Canada's obligations under the Canada-United States-Mexico Agreement ("CUSMA"), Canada agreed to implement a patent term adjustment ("PTA")...

I've lost count of the number of times that I've heard the following: "I would like to patent my company's logo;" or "Our software code is trademarked;" or "We need to copyright our new medical device."

On January 1, 2025, Canada implemented a patent term adjustment ("PTA") system to account for unreasonable delays by the Canadian Intellectual Property Office ("CIPO") in issuing a patent.

On October 30, 2019, the new Canadian Patent Act and Rules will come into force introducing substantive administrative procedural changes.

In order for a factual basis and/or sound line of reasoning for predicted utility to be considered sufficiently disclosed in the common general knowledge and, therefore, not required to be disclosed...

On January 1, 2024, fees that are payable to the Canadian Intellectual Property Office (CIPO) for industrial design applications and registrations will increase by at least 25 percent.

Eli Lilly's arguably last ditch attempt to challenge the Canadian courts' invalidation of two Canadian patents relating to the drugs olanzapine (Zyprexa™) and atomoxetine (Strattera™), using a NAFTA...

As a patent practitioner, one of the questions I often get asked is whether distributed ledger technology (DLT), such as blockchain, is patentable.